About this trial
Falls are a significant issue for patients with knee osteoarthritis, as they can lead to hospitalization or even more severe consequences. Therefore, it is crucial to assess fall risk early in rehabilitation clinics. Sarcopenia, which is the reduction of muscle mass, increases the risk of falls. This study involved 250 adults with knee osteoarthritis, using a technology called POCUS to assess muscle mass, combined with other tests to track fall incidents over three months. The study is expected to find correlations between falls and factors like muscle mass and grip strength. This information can help doctors better predict which patients are at risk of falling and take preventive measures early. Future research will explore the effectiveness of different prevention strategies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Males and females aged 60 and above, who are willing to sign an informed consent form.
Participants must have a clinically confirmed diagnosis of knee osteoarthritis.
Participants must have received at least one treatment in the outpatient rehabilitation department during the study period.
Participants must be able to walk independently, even with the aid of assistive devices.
Disqualifiers
Individuals who have undergone lower limb surgery or have significant lower limb deformities.
Individuals with severe cognitive impairment who are unable to understand or comply with the study procedures.
Individuals who cannot communicate in a language understandable by the research team.
Individuals with severe comorbidities that affect assessment or treatment (e.g., unable to safely complete assessments or treatments).
Trial population
Participants eligible for the study include males and females aged 60 and above who are willing to sign an informed consent form, have a clinically confirmed diagnosis of knee osteoarthritis, have received at least one treatment in the outpatient rehabilitation department during the study period, and can walk independently, even with the use of assistive devices.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Fall Incident Tracking
Participants will be monitored for fall incidents over a three-month period, and the accuracy of the model predictions will be analyzed.
Secondary outcomes
Grip strength testing
Measures the maximum strength of hand and forearm muscles using a hand dynamometer. It reflects overall muscle function and the ability to perform daily tasks. Results are reported in kilograms or pounds.
POCUS Assessment
Point-of-care ultrasound is used to measure participants' muscle mass
Sarcopenia Risk Assessment Questionnaire (SARC-F)
An assessment tool designed to determine the risk of sarcopenia in individuals. Scale: The SARC-F consists of five questions scored from 0 to 10, with higher scores indicating a greater risk of sarcopenia.
Bioelectrical Impedance Analysis (BIA) Measurement
Conduct bioelectrical impedance measurements to assess body composition, including fat mass and lean body mass. Unit of Measure: Results are typically presented in kilograms and percentage for fat mass and lean body mass.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
National Taiwan University Clinical Trial Center
Lead sponsor
National Taiwan University Hospital
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: